2024
ISPAD Clinical Practice Consensus Guidelines 2024: Diabetes Technologies: Insulin Delivery.
Biester T, Berget C, Boughton C, Cudizio L, Ekhlaspour L, Hilliard M, Reddy L, Sap Ngo Um S, Schoelwer M, Sherr J, Dovc K. ISPAD Clinical Practice Consensus Guidelines 2024: Diabetes Technologies: Insulin Delivery. Hormone Research In Paediatrics 2024, 1-34. PMID: 39657603, DOI: 10.1159/000543034.Peer-Reviewed Original Research
2010
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA. Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes. New England Journal Of Medicine 2010, 363: 311-320. PMID: 20587585, DOI: 10.1056/nejmoa1002853.Peer-Reviewed Original ResearchConceptsInjection therapy groupPump-therapy groupSensor-augmented pump therapyGlycated hemoglobin levelsHemoglobin levelsType 1 diabetesPump therapyBaseline glycated hemoglobin levelMultiple daily insulin injectionsType 1 diabetes mellitusGlycated haemoglobin targetPrimary end pointProportion of patientsDaily insulin injectionsSignificant weight gainRecombinant insulin analogueHemoglobin targetsInjection therapyDiabetes mellitusSevere hypoglycemiaInsulin injectionsClinical teamInsulin analoguesEnd pointTherapy